Comparison of Flow Reduction Efficacy of Nominal and Oversized Flow Diverters Using a Novel Measurement-assisted in Silico Method
-
Published:2024-04-23
Issue:3
Volume:34
Page:675-684
-
ISSN:1869-1439
-
Container-title:Clinical Neuroradiology
-
language:en
-
Short-container-title:Clin Neuroradiol
Author:
Csippa BenjaminORCID, Sándor Levente, Závodszky Gábor, Szikora István, Paál György
Abstract
Abstract
Purpose
The high efficacy of flow diverters (FD) in the case of wide-neck aneurysms is well demonstrated, yet new challenges have arisen because of reported posttreatment failures and the growing number of new generation of devices. Our aim is to present a measurement-supported in silico workflow that automates the virtual deployment and subsequent hemodynamic analysis of FDs. In this work, the objective is to analyze the effects of FD deployment variability of two manufacturers on posttreatment flow reduction.
Methods
The virtual deployment procedure is based on detailed mechanical calibration of the flow diverters, while the flow representation is based on hydrodynamic resistance (HR) measurements. Computational fluid dynamic simulations resulted in 5 untreated and 80 virtually treated scenarios, including 2 FD designs in nominal and oversized deployment states. The simulated aneurysmal velocity reduction (AMVR) is correlated with the HR values and deployment scenarios.
Results
The linear HR coefficient and AMVR revealed a power-law relationship considering all 80 deployments. In nominal deployment scenarios, a significantly larger average AMVR was obtained (60.3%) for the 64-wire FDs than for 48-wire FDs (51.9%). In oversized deployments, the average AMVR was almost the same for 64-wire and 48-wire device types, 27.5% and 25.7%, respectively.
Conclusion
The applicability of our numerical workflow was demonstrated, also in large-scale hemodynamic investigations. The study revealed a robust power-law relationship between a HR coefficient and AMVR. Furthermore, the 64 wire configurations in nominal sizing produced a significantly higher posttreatment flow reduction, replicating the results of other in vitro studies.
Funder
H2020 Societal Challenges Nemzeti Kutatási, Fejlesztési és Innovaciós Alap Budapest University of Technology and Economics
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Szikora I, Berentei Z, Kulcsar Z, Marosfoi M, Vajda ZS, Lee W, Berez A, Nelson PK. Treatment of Intracranial Aneurysms by Functional Reconstruction of the Parent Artery: The. Budapest: Experience with the Pipeline Embolization Device. Am J Neuroradiol; 2010. https://doi.org/10.3174/ajnr.a2023. 2. Becske T, Kallmes DF, Saatci I, McDougall CG, Szikora I, Lanzino G, Moran JC, Woo HH, Lopes KD, Berez A, Cher JD, Siddiqui HA, Levy IE, Albuquerque CF, Fiorella JD, Berentei Z, Marosfoi M, Cekirge HS, Nelson PK. Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology. 2013; https://doi.org/10.1148/radiol.13120099. 3. Hanel RA, Cortez GM, Lopes DK, Nelson PK, Siddiqui AH, Jabbour P, Pereira VM, Szikora I, Zaidat O, Bettegowda C, Colby GP, Mokin M, Schirmer MC, Hellinger FR, Given C, Krings T, Taussky P, Toth G, Fraser FR, Chen M, Priest R, Kan P, Fiorella P, Frei D, Aagaard-Kienitz B, Diaz O, Am M, Cawley MC, Puri AS, Kallmes DF. Prospective study on embolization of intracranial aneurysms with the pipeline device (PREMIER study): 3‑year results with the application of a flow diverter specific occlusion classification Hemorrhagic stroke. J Neurointerv Surg. 2022; https://doi.org/10.1136/neurintsurg-2021-018501. 4. Vivanco-Suarez J, Mendez-Ruiz A, Farooqui M, Bekelis K, Singer JA, Javed K, Altschul DJ, Fifi JT, Matsoukas S, Cooper J, Al-Mufti F, Gross B, Jankowitz B, Kan PT, Hafeez M, Orru E, Dajles A, Galecio-Castillo M, Zevallos CB, Wakhloo AK, Ortega-Gutierrez S. Safety and efficacy of the surpass streamline for intracranial aneurysms (SESSIA): A multi-center US experience pooled analysis. Interv Neuroradiol. 2022; https://doi.org/10.1177/15910199221118148. 5. Mcdougall CG, Diaz O, Boulos A, Siddiqui AH, Caplan J, Fifi JT, Turk AS, Kayan Y, Jabbour P, Kim LJ, Hetts SW, Cooke DL, Dowd CF. Safety and efficacy results of the Flow Redirection Endoluminal Device (FRED) stent system in the treatment of intracranial aneurysms. US: pivotal trial Hemorrhagic stroke. J Neurointerv Surg; 2022. https://doi.org/10.1136/neurintsurg-2021-017469.
|
|